Autophagy inhibitor combination strategies for pancreatic cancer

被引：3
|
作者：
Iain Dickson
机构：
[1] Nature Reviews Gastroenterology & Hepatology,
来源：
Nature Reviews Gastroenterology & Hepatology | 2019年 / 16卷 / 5期
关键词：
D O I：
10.1038/s41575-019-0136-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：262 / 263
页数：1
相关论文
共 50 条
  • [1] Autophagy inhibitor combination strategies for pancreatic cancer
    Dickson, Iain
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (05) : 262 - 263
  • [2] Novel autophagy inhibitor to treat pancreatic cancer
    Ramachandran, Mythili
    Ma, Zhao
    Li, Yuanpei
    CANCER RESEARCH, 2021, 81 (13)
  • [3] Autophagy in cancer resistance to paclitaxel: Development of combination strategies
    Skubnik, Jan
    Pavlickova, Vladimira Svobodova
    Ruml, Tomas
    Rimpelova, Silvie
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [4] Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy
    Liu, Ting
    Zhang, Jing
    Li, Kangdi
    Deng, Lingnan
    Wang, Hongxiang
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [5] Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
    Bryant, Kirsten L.
    Stalnecker, Clint A.
    Zeitouni, Daniel
    Klomp, Jennifer E.
    Peng, Sen
    Tikunov, Andrey P.
    Gunda, Venugopal
    Pierobon, Mariaelena
    Waters, Andrew M.
    George, Samuel D.
    Tomar, Garima
    Papke, Bjorn
    Hobbs, G. Aaron
    Yan, Liang
    Hayes, Tikvah K.
    Diehl, J. Nathaniel
    Goode, Gennifer D.
    Chaika, Nina V.
    Wang, Yingxue
    Zhang, Guo-Fang
    Witkiewicz, Agnieszka K.
    Knudsen, Erik S.
    Petricoin, Emanuel F., III
    Singh, Pankaj K.
    Macdonald, Jeffrey M.
    Tran, Nhan L.
    Lyssiotis, Costas A.
    Ying, Haoqiang
    Kimmelman, Alec C.
    Cox, Adrienne D.
    Der, Channing J.
    NATURE MEDICINE, 2019, 25 (04) : 628 - +
  • [6] Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
    Kirsten L. Bryant
    Clint A. Stalnecker
    Daniel Zeitouni
    Jennifer E. Klomp
    Sen Peng
    Andrey P. Tikunov
    Venugopal Gunda
    Mariaelena Pierobon
    Andrew M. Waters
    Samuel D. George
    Garima Tomar
    Björn Papke
    G. Aaron Hobbs
    Liang Yan
    Tikvah K. Hayes
    J. Nathaniel Diehl
    Gennifer D. Goode
    Nina V. Chaika
    Yingxue Wang
    Guo-Fang Zhang
    Agnieszka K. Witkiewicz
    Erik S. Knudsen
    Emanuel F. Petricoin
    Pankaj K. Singh
    Jeffrey M. Macdonald
    Nhan L. Tran
    Costas A. Lyssiotis
    Haoqiang Ying
    Alec C. Kimmelman
    Adrienne D. Cox
    Channing J. Der
    Nature Medicine, 2019, 25 : 628 - 640
  • [7] Combination inhibitor strategies targeting KRAS effector signaling in KRAS-mutant pancreatic cancer.
    Ozkan-Dagliyan, Irem
    Goodwin, Craig M.
    Bryant, Kirsten L.
    George, Samuel D.
    Lucas, Kelly
    Gautam, Prson
    Wennerberg, Krister
    Cox, Adrienne D.
    Der, Channing J.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 68 - 68
  • [8] Preclinical development of a combination inhibitor strategy to block K-Ras effector signaling and autophagy for pancreatic cancer treatment
    Bryant, Kirsten L.
    Hayes, Tikvah K.
    Zeitouni, Daniel
    George, Samuel A.
    Kher, Swapnil
    Samatar, Ahmed A.
    Wood, Kris C.
    Kimmelman, Alec C.
    Der, Channing J.
    CANCER RESEARCH, 2016, 76
  • [9] Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer
    Wenhao Luo
    Lianfang Zheng
    Taiping Tai Zhang
    Medical Oncology, 2021, 38
  • [10] Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer
    Luo, Wenhao
    Zheng, Lianfang
    Zhang, Taiping Tai
    MEDICAL ONCOLOGY, 2021, 38 (06)
12345